Our data show that suramin, a small molecule drug used in the treatment of parasitic diseases, has the capacity to induce Tau condensation, disrupts preformed Tau:polyanion coacervates, and prevents the formation of pathological seeding activity evolving in Tau coacervates. Here, MAPT is linked to parasitic infectious disease.